| Fund ID | 805-4025066284 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 99% |
| Fund | Type | Gross assets |
|---|---|---|
| 03. Patient Square Equity Partners, LP | Private Equity | $2.45B |
| 04. Patient Square Equity Partners-A, LP | Private Equity | $2.28B |
| 05. Blackwell Capital Partners, LP | Private Equity | $1.6B |
12. Psc Ginger Coinvest II, LP reports $36.5 million in gross assets, among the top 59% of private funds by size.
12. Psc Ginger Coinvest II, LP is managed by Patient Square Capital, LP.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.